Perceptions of CAH self-management and stress dosing in relation to health-related quality of life as measured by CAHQLCAH自我管理及应激剂量与CAHQL测量的健康相关生命质量的关系认知Frontiers in EndocrinologyIF4.62026-05-250OAAI
Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals21-羟化酶缺陷症在457个个体中临床和生化表型在基因型谱上的分布JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12025-10-011OAAI
CAHQL: A Patient-Reported Outcome Instrument to Assess Health-Related Quality of Life in Congenital Adrenal HyperplasiaJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12024-05-060PRE
Course of COVID-19 infection in patients with congenital adrenal hyperplasiaFRONTIERS IN ENDOCRINOLOGYIF4.62024-02-091OAAI
Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal HyperplasiaJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12023-08-292OA